Research has shown that expression of SOCS-3 is decreased in many malignant tumor tissues and cell lines, such as head and neck squamous cell carcinoma, liver cancer, renal carcinoma, melanoma, and prostate cancer [11–13]. Here, SOCS3 is linked to cancer.